Document is current
Any future updates will be listed below
-
Authors
Schön, Jacob https://orcid.org/0000-0002-9801-7972
Barut, G. Tuba https://orcid.org/0000-0002-3863-0775
Trüeb, Bettina Salome https://orcid.org/0000-0001-7256-9245
Halwe, Nico Joel https://orcid.org/0000-0002-7983-2808
Berenguer Veiga, Inês
Kratzel, Annika
Ulrich, Lorenz https://orcid.org/0000-0001-5004-806X
Kelly, Jenna N. https://orcid.org/0000-0001-7265-2233
Brügger, Melanie https://orcid.org/0000-0003-3810-7682
Wylezich, Claudia https://orcid.org/0000-0002-0436-4480
Taddeo, Adriano https://orcid.org/0000-0003-3281-1548
Aguiar Moreira, Etori https://orcid.org/0000-0003-2976-5325
Túrós, Demeter
Grau-Roma, Llorenç https://orcid.org/0000-0002-9406-8844
Ahrens, Ann Kathrin https://orcid.org/0009-0007-3635-423X
Schlottau, Kore https://orcid.org/0000-0002-3999-0393
Britzke, Tobias https://orcid.org/0009-0001-8177-4766
Breithaupt, Angele https://orcid.org/0000-0002-6373-5923
Corleis, Björn
Kochmann, Jana https://orcid.org/0000-0003-0955-7182
Oliveira Esteves, Blandina I.
Almeida, Lea https://orcid.org/0009-0007-9945-0894
Thomann, Lisa https://orcid.org/0000-0003-3530-0524
Devisme, Christelle
Stalder, Hanspeter https://orcid.org/0000-0003-0763-6469
Steiner, Silvio https://orcid.org/0000-0003-1999-1425
Ochsenbein, Sarah https://orcid.org/0009-0005-1796-4505
Schmied, Kimberly https://orcid.org/0000-0002-6158-7074
Labroussaa, Fabien
Jores, Jörg https://orcid.org/0000-0003-3790-5746
V’kovski, Philip
Cmiljanovic, Vladimir
Alves, Marco P. https://orcid.org/0000-0002-8495-6098
Benarafa, Charaf https://orcid.org/0000-0002-2049-7769
Ebert, Nadine
Hoffmann, Donata https://orcid.org/0000-0003-4552-031X
Beer, Martin https://orcid.org/0000-0002-0598-5254
Thiel, Volker
-
Funding
Funding for this research was provided by:
RocketVax AG funded project
Novartis Stiftung für Medizinisch-Biologische Forschung (22B099)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (31CA30_196062, 310030B_201278, 4078P0_198473)
- License Information
-
More Information
Article History
Received: 25 July 2023
Accepted: 10 June 2024
First Online: 12 July 2024
Competing interests
: Related to this work, the University of Bern has filed a patent application for the use of OTS-206 and OTS-228 as vaccine. In this application, J.S., G.T.B., B.S.T., N.J.H., A.K., L.U., F.L., J.J., N.E., D.H., M.B. and V.T. are named as inventors. The University of Bern and the Friedrich-Loeffler Institute are collaborating with RocketVax AG for the development of OTS vaccines and receive funding for research. V.T. is consulting for RocketVax AG. P.V. and V.C. are employees of RocketVax AG. The remaining authors declare no competing interests.
